Nestec S.a.

Danisco A/s

Societe Des Produits Nestle S.a.

L'oreal

Nectec S.a.

Annick Mercenier

Sophie Helene Nutten

Guenolee Prioult

Adrian Zuercher

Sebastien Holvoet

Monique Julita

Clara Lucia Garcia-Rodenas

Valerie Petit

Gregory Leyer

Bruno Pot

Véronique Dennin

Sophie Nutten

Florence Rochat

Stephanie Blum-Sperisen

Marie-Claire Fichot

Anurag Singh

Antoine Wermeille

Audrey Demont

Lionel Breton

Audrey Gueniche

Fabiola Dionisi

Stephane Duboux

Michael Affolter

Isabelle Bureau-Franz

Gabriela Bergonzelli Degonda

Lucas Actis Goretta

Francoise Maynard

Alexandre Panchaud

Michela Zuccolo

Swantje Duncker

Muzi Tangyu

Stéphanie Blum-Sperisen

Guénolé Prioult

Clara Garcia-Rodenas

Velerie Petit

Marietta Weiss

Grégory Leyer

Sébastien Holvoet

Françoise Maynard

Valérie Petit

Adrian Walter Zuercher

Guénolée Prioult

Use of a sugar selected from lactose, fructose and raffinose, for increasing serpin expression instrain CNCM I-2618.

Serpin production

The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of non-replicatingLa1 NCC533 (deposit number CNCM I-1225) for use in the treatment or prevention of disorders related to the immune system including infections.

La1 NCC533 (CNCM I-1225) and immune disorders

The present invention relates to the topical use ofsubsp.CNCM I-2618, as a pro-pigmenting agent, in particular in the prevention and/or treatment of alterations of skin and/or hair color homogeneity and for creating a uniform complexion.

Use of probiotic micro-organisms as an agent that promotes the synthesis of melanin

The present invention relates to epicatechin for use in the prevention or reduction of symptoms of an allergic disorder and/or an allergic reaction. The invention further relates to epicatechin for said use in the form of food, food product, food supplement or pharmaceutical products.

Epicatechin for alleviating symptoms of allergy

A composition comprising specificstrains is provided for reducing the symptoms of allergies originating from food, respiratory or contact allergens. Preferably the composition reduces symptoms of allergies (secondary prevention) while also able to reduce sensitization (primary prevention).

[object Object]

CNCM I-3865 (NCC2950), a composition comprisingCNCM I-3865 (NCC2950), and the use ofCNCM I-3865 (NCC2950) in the prevention or treatment of allergic diarrhoea are provided. TheCNCM I-3865 (NCC2950) can be in a non-replicating form and can be administered to at least partially treat allergic diarrhoea or at least partially reduce the risk of developing allergic diarrhoea.

Prevention and treatment of allergic diarrhea

A composition including protein hydrolysates derived from milk is obtained by the treatment of enzymes derived from microorganisms. A trypsin-like enzyme and a chemotrypsin-like enzyme are used. The composition is in particular intended for inducing tolerance in infants with the effect of modulating the potential occurrence of allergies later in life. The composition can also be used in sick adult patients. Preferably the composition is an infant formula, infant follow-up formula, growing-up milk or baby food or an enteral complete nutritional composition.

Milk-based protein hydrolysates and infant formulae and nutritional compositions made thereof

The invention relates to the use, in the manufacture of a medicament or a therapeutic nutritional composition for preventing or reducing inflammation in a mammal, ofATCC BAAA-999.

A complete nutritional composition comprisingstrains or probiotic is provided for reducing the symptoms of allergies originating from food allergens in young children or infants. Preferably the composition reduces symptoms of allergies (secondary prevention) and also reduces sensitization (primary prevention). The composition comprises a probiotic of the genus

The present invention relates to the field of infant nutrition. In particular, the present invention relates to infant feeding formulas comprising probiotic micro-organisms. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example.

Infant feeding formulas comprising probiotic micro-organisms

The present invention relates to non-replicating probiotic micro-organisms and their health benefits. For example, the present invention relates to compositions comprising non-replicating probiotic micro-organisms for use in the treatment of prevention of upper respiratory tract infections and/or their symptoms. Embodiments of the present invention provide means to help parents to protect their children from such upper respiratory tract infections.

Non-replicating probiotic micro-organisms protect against upper respiratory tract infections

The present invention relates to non-replicating probiotic micro-organisms and their health benefits. In particular, the present invention provides a means to help parents to protect their children from gastro-intestinal infections, in particular diarrhea. One embodiment of the present invention relates to a composition comprising non-replicating probiotic micro-organisms for use in the prevention or treatment of gastrointestinal infections in children.

Non-replicating probiotic micro-organisms protect children against gastrointestinal infections

The present invention generally relates to the field of pro biotic micro-organisms, in particular to the field of non-replicating probiotic micro-organisms. Embodiments of the present invention relate to compositions comprising probiotic microorganisms that were rendered non-replicating by extrusion. Such compositions may be used to treat or prevent disorders that are related to a compromised immune system.

Extruded non-replicating probiotic micro-organisms and their health benefits

A nutritional composition comprising a partially hydrolyzed milk protein having a degree of hydrolysis between 15 and 25% and 50 to 1000 nanograms of TGF-&#x3b2; per 100 ml of ready to consume composition and methods for the primary prevention of allergic reactions to newly introduced dietary protein at weaning and the prevention of development of atopic diseases in a young mammal at weaning comprising feeding to the young mammal a therapeutic amount of the composition are disclosed.

Prevention of allergy at weaning

A complete nutritional composition comprisingstrains or probiotic is provided for reducing the symptoms of allergies in different groups of patients such as allergies originating from food allergens in young children or infants and respiratory allergens in children, adults and household pets. Preferably the composition reduces symptoms of allergies (secondary prevention) while not significantly affecting sensitization (primary prevention). The composition comprises a probiotic of the genus

Growing community of inventors

Bussigny, Switzerland

Annick Mercenier